Irrefutable evidence for the use of docetaxel in newly diagnosed metastatic prostate cancer: results from the STAMPEDE and CHAARTED trials.

BMC Med · 2015 · PMC4687286 · PMID 26695172

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A meta-analysis of the available data, also incorporating a smaller study by the French Genitourinary Tumor Group (GETUG-15) that showed a similar trend but did not reach statistical significance, is reported by Vale et al.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.